SC 13D

Company

Galera Therapeutics, Inc.

Filed

November 20, 2019

Accession Number

0001104659-19-065570

A Schedule 13D is filed when an investor acquires more than 5% of a company's shares with an intent to influence control. Learn more about SC 13D filings →